Cwikla JB - Search Results

1

Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study.

Cwikla JB, Sankowski A, Seklecka N, Buscombe JR, Nasierowska-Guttmejer A, Jeziorski KG, Mikolajczak R, Pawlak D, Stepien K, Walecki J. Cwikla JB, et al. Ann Oncol. 2010 Apr;21(4):787-794. doi: 10.1093/annonc/mdp372. Epub 2009 Oct 15. Ann Oncol. 2010. PMID: 19833821 Free article. Clinical Trial.

2

Uptake of Tc-99m MIBI related to tumour size and type.

Buscombe JR, Cwikla JB, Thakrar DS, Hilson AJ. Buscombe JR, et al. Among authors: cwikla jb. Anticancer Res. 1997 May-Jun;17(3B):1693-4. Anticancer Res. 1997. PMID: 9179220

3

The effect of chemotherapy on the uptake of technetium-99m sestamibi in breast cancer.

Cwikla JB, Buscombe JR, Barlow RV, Kelleher SM, Parbhoo SP, Crow J, Deery A, Jones AL, Hilson AJ. Cwikla JB, et al. Eur J Nucl Med. 1997 Sep;24(9):1175-8. doi: 10.1007/BF01254253. Eur J Nucl Med. 1997. PMID: 9283114

4

Scintigraphic imaging of breast cancer: a review.

Buscombe JR, Cwikla JB, Thakrar DS, Hilson AJ. Buscombe JR, et al. Among authors: cwikla jb. Nucl Med Commun. 1997 Aug;18(8):698-709. doi: 10.1097/00006231-199708000-00003. Nucl Med Commun. 1997. PMID: 9293500 Review.

5

Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy.

Cwikla JB, Buscombe JR, Kelleher SM, Parbhoo SP, Thakrar DS, Hinton J, Deery AR, Crow J, Hilson AJ. Cwikla JB, et al. Clin Radiol. 1998 Apr;53(4):274-80. doi: 10.1016/s0009-9260(98)80126-8. Clin Radiol. 1998. PMID: 9585043 Clinical Trial.

6

Use of 99Tcm-MIBI in the assessment of patients with suspected recurrent breast cancer.

Cwikla JB, Buscombe JR, Parbhoo SP, Kelleher SM, Thakrar DS, Hinton J, Crow J, Deery A, Hilson AJ. Cwikla JB, et al. Nucl Med Commun. 1998 Jul;19(7):649-55. doi: 10.1097/00006231-199807000-00006. Nucl Med Commun. 1998. PMID: 9853345 Clinical Trial.

7

Prone SPET scintimammography.

Buscombe JR, Cwikla JB, Thakrar DS, Parbhoo SP, Hilson AJ. Buscombe JR, et al. Among authors: cwikla jb. Nucl Med Commun. 1999 Mar;20(3):237-45. doi: 10.1097/00006231-199903000-00006. Nucl Med Commun. 1999. PMID: 10093073 Clinical Trial.

8

Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.

Cwikla JB, Buscombe JR, Kolasinska AD, Parbhoo SP, Thakrar DS, Hilson AJ. Cwikla JB, et al. Anticancer Res. 1999 May-Jun;19(3B):2299-304. Anticancer Res. 1999. PMID: 10472348

9

Tc-99m MIBI in suspected recurrent breast cancer.

Cwikla JB, Kolasinska A, Buscombe JR, Hilson AJ. Cwikla JB, et al. Cancer Biother Radiopharm. 2000 Aug;15(4):367-72. doi: 10.1089/cbr.2000.15.367. Cancer Biother Radiopharm. 2000. PMID: 11041021 Clinical Trial.

10

Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves.

Buscombe JR, Cwikla JB, Holloway B, Hilson AJ. Buscombe JR, et al. Among authors: cwikla jb. J Nucl Med. 2001 Jan;42(1):3-8. J Nucl Med. 2001. PMID: 11197976 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page